UPDATED Sep 23, 2025
Discover small cap Australian Pharmaceuticals & Biotech companies that are on the ASX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
HXL | AU$0.013 | 0% | -18.8% | AU$2.2m | n/a | PS35.2x | n/a | n/a | ||
BP8 | AU$0.002 | 0% | 0% | AU$2.1m | n/a | PS7.3x | n/a | n/a | ||
VTL | AU$0.02 | 0% | n/a | AU$2.8m | n/a | PS112.4x | n/a | n/a | ||
VBS | AU$0.06 | 0% | -25.0% | AU$3.2m | n/a | PS6.7x | n/a | n/a | ||
1AD | AU$0.003 | -14.3% | -84.2% | AU$3.5m | n/a | PS5.1x | n/a | n/a | ||
ANR | AU$0.017 | 21.4% | -76.4% | AU$3.6m | n/a | PS3.7x | n/a | n/a | ||
BOD | AU$0.024 | 0% | -65.2% | AU$4.3m | n/a | PS1.3x | n/a | n/a | ||
BIT | AU$0.0035 | 16.7% | -80.6% | AU$4.6m | n/a | PS2.6x | n/a | n/a | ||
ZLD | AU$0.42 | 10.5% | -48.5% | AU$5.0m | n/a | PS7617.1x | n/a | n/a | ||
GTG | AU$0.039 | 0% | -68.8% | AU$5.7m | n/a | PB3.1x | n/a | n/a | ||
ACR | AU$0.014 | 0% | -75.9% | AU$5.7m | n/a | PS4.8x | E121.1% | 0% | ||
PAB | AU$0.0015 | 50.0% | -68.8% | AU$6.9m | n/a | PS8.3x | n/a | n/a | ||
EPN | AU$0.024 | 0% | 20.0% | AU$7.2m | n/a | PB0.8x | n/a | n/a | ||
CAN | AU$0.011 | 0% | -76.6% | AU$7.3m | n/a | PE-0.3x | n/a | n/a | ||
ECS | AU$0.006 | 20.0% | -66.7% | AU$7.8m | n/a | PB0.3x | n/a | n/a | ||
RGT | AU$0.10 | -9.1% | -69.2% | AU$7.8m | n/a | PS43.1x | n/a | n/a | ||
MEM | AU$0.004 | -11.1% | -55.6% | AU$7.9m | n/a | PS15.1x | n/a | n/a | ||
IVX | AU$0.11 | -8.3% | -63.3% | AU$9.4m | n/a | PB1.1x | n/a | n/a | ||
CHM | AU$0.003 | 0% | -78.6% | AU$9.8m | n/a | PB4.9x | n/a | n/a | ||
PER | AU$0.011 | 10.5% | -89.4% | AU$11.4m | n/a | PS6.3x | E-13.9% | n/a | ||
CMB | AU$0.52 | 3.0% | 38.7% | AU$11.9m | n/a | n/a | n/a | n/a | ||
IXC | AU$0.16 | 23.1% | 116.2% | AU$12.0m | n/a | PS52.5x | n/a | n/a | ||
1AI | AU$0.008 | 14.3% | 33.3% | AU$13.5m | n/a | PB6.1x | n/a | n/a | ||
FRE | AU$0.065 | -3.0% | 18.2% | AU$16.2m | n/a | PS31.5x | n/a | n/a |